Dublin / Wynnewood / San Francisco / Fairfield / Helsinki / San Antonio / Tel Aviv / Antonio / La Jolla / Billerica / Monica / Cleveland / Tampa / Chicago / Sacramento / /
Company
Sentinel / Navidea Biopharmaceuticals Inc. / Ligand / Liu LC / mCi / Creative Commons / /
Country
United States / Israel / / /
Event
FDA Phase / /
Facility
3Sourasky Medical Center / University of Alabama / Davis Cancer Center / Wayne Cancer Institute / Diego Moores Center Institute / Case Western Reserve University / Lee Moffitt Cancer Center / Pacific Medical Center / University of California / Hospitals Seidman Cancer Center / Lankenau Hospital / /
IndustryTerm
node imaging / injection site / imaging / tumor site / study site / treatment of cutaneous melanoma / chemical structure / /
MedicalCondition
melanoma patients receiving / Clinically Node-Negative Cutaneous Melanoma Vernon K. Sondak / JE / another investigational drug study Melanoma / cellulitis / nausea / syncope / melanoma SLN / melanoma / delayed hypersensitivity / tachycardia and myocardial infarction / bradycardia / breast cancer / both melanoma / asthma / prior breast cancer / tumor / enlarged lymph nodes Known hypersensitivity / extremity primary melanoma / nodal metastases / early stage melanoma / primary melanoma / III Melanoma Tumor-positive / pain / vomiting / metastatic cancer / intermediatethickness melanomas / skin cancers / cutaneous melanoma / primary cutaneous melanoma / melanoma SLNs / primary tumor / /
MedicalTreatment
day surgery / incision / chemotherapy / radiotherapy / surgery / surgical treatment / immunotherapy / radiation / /
Organization
University of California / Society of Nuclear Medicine Annual / Case Western Reserve University / Cleveland / American Society of Clinical Oncology Annual / Lankenau Hospital / MD9 H. Lee Moffitt Cancer Center / University of Alabama / Birmingham / 3Sourasky Medical Center / 5California Pacific Medical Center / US Food and Drug Administration / 9San Diego Moores Center Institute / 7MetroHealth Medical Center / Western Institutional Review Board / 4University Hospitals Seidman Cancer Center / 6John Wayne Cancer Institute / 8UC Davis Cancer Center / /
Person
Helen Krontiras / Dennis W. King / Jonathan S. Zager / Lori Christman / Tilmanocept Blue Dye / Jane L. Messina / Bruce J. Averbook / Ned Carp / Frederick O. Cope / Navidea Biopharmaceuticals / Arch Surg / Julian Kim / Vernon K. Sondak / V. K. Sondak / Mark B. Faries / Steve R. Martinez / Kenneth Deck / Wendy L. Metz / Stanley P. L. Leong / Ann Surg Oncol / Vital Blue Dye / Christopher A. Puleo / /
Position
investigator / first author / consultant / author / surgeon / King / /
Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma Vernon K. Sondak, Dennis W. King,